Sanofi Consumer Healthcare India
Sanofi Consumer Healthcare India Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Sanofi Consumer Healthcare India Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Sanofi Consumer Healthcare India Ltd trades at a P/E of 41.29× and P/B of 27.69×.
Valuation
Profitability
Growth
Financial Health
Sanofi Consumer Healthcare India Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Sanofi Consumer Healthcare India Ltd, switchable between annual and quarterly views, consolidated or standalone.
Sanofi Consumer Healthcare India Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹10,697.72 Cr and reported EPS of ₹111.82.
Sanofi Consumer Healthcare India segment analysis: revenue and profit mix.
Disclosed business segments at Sanofi Consumer Healthcare India with their share of revenue and profit, switchable between consolidated and standalone reporting.
Sanofi Consumer Healthcare India discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Sanofi Consumer Healthcare India Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Sanofi Consumer Healthcare India Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Sanofi Consumer Healthcare India Ltd's investment case rests on 9 positive markers and 8 flagged concerns drawn from the latest reported filings.
What you're getting.
Outstanding operational efficiency with ROCE 111.00% and ROE 83.80%.
Robust quarterly performance. sales grew 28.20%, net profit 23.00%.
Strong financial stability demonstrated by a very low debt-to-equity of 0.07.
Impressive Operating Profit Margin (OPM) of 34.27% showcasing efficient cost management.
Benefits from parent Sanofi's established brand, R&D, and distribution network.
What can break it.
High P/E ratio of 54.59 suggests a richly valued stock.
Stock price significantly below 52-week high, indicating recent pressure.
Negative short-term price returns. -7.31% (13W) and -4.99% (26W).
Declining institutional investor confidence with FII and DII stake reduction.
Intense competition from established pharmaceutical and healthcare players.
What would change my mind.
Trim if P/E re-rates above 54. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 6.96. Balance sheet risk re-prices growth multiples fast.
Income thesis breaks if the dividend is cut or yield falls below 0.81%.
Sanofi Consumer Healthcare India Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Sanofi Consumer Healthcare India Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Sanofi Consumer Healthcare India Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Sanofi Consumer Healthcare India Ltd — derived from the live tape, not yesterday's close.
Sanofi Consumer Healthcare India Ltd last traded at ₹4,616.9 with an intraday range of ₹4,592–₹4,680 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹4616.90| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 4843.27 | +226.37 | +4.90% |
| R3 | 4755.27 | +138.37 | +3.00% |
| R2 | 4717.63 | +100.73 | +2.18% |
| R1 | 4667.27 | +50.37 | +1.09% |
| PIVOT | 4629.63 | 12.73 | 0.28% |
| CURRENT | 4616.90 | — | — |
| S1 | 4403.27 | -213.63 | -4.63% |
| S2 | 4491.27 | -125.63 | -2.72% |
| S3 | 4541.63 | -75.27 | -1.63% |
| S4 | 4579.27 | -37.63 | -0.82% |
SANOFICONR is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: 4600 ~ 4680
Trading Inside opening range
Sanofi Consumer Healthcare India Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Sanofi Consumer Healthcare India Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Sanofi Consumer Healthcare India Ltd stood at 57.6% of traded volume, against a 20-day average of 54.0%.
Sanofi Consumer Healthcare India announcements: results, concalls, ratings, M&A.
Filings Sanofi Consumer Healthcare India sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Sanofi Consumer Healthcare India files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 80 documents below.
Copy of Newspaper Publication
Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication of 3rd Annual General Meeting of the Company
Copy of Newspaper Publication
Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication regarding the convening of the 3rd Annual…
Change in Auditors
Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Change in Auditors of the company.
Copy of Newspaper Publication
Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication
Press Release
Sanofi Consumer Healthcare India Limited has informed the Exchange regarding a press release dated April 28, 2026, titled "Sanofi Consumer Healthcare…
Investor decks & rating reports.
Sanofi Consumer Healthcare India insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Sanofi Consumer Healthcare India as reported to SEBI — buying and selling signals from the people who know the business best.
Sanofi Consumer Healthcare India insider activity below tracks 1 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Opal Bidco SAS | Insider | 11 Jun 2025 | buy | +25.05 L | ₹1,247.82 Cr | ₹4,982.05 |
Sanofi Consumer Healthcare India dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Sanofi Consumer Healthcare India has declared, sequenced by announce and record date.
Sanofi Consumer Healthcare India corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Sanofi Consumer Healthcare India Ltd: business, sector, key facts.
What Sanofi Consumer Healthcare India Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Sanofi Consumer Healthcare India Ltd operates in the Healthcare, listed as NSE: SANOFICONR, BSE: 544250.
Sanofi Consumer Healthcare India Ltd
Sanofi Consumer Healthcare India Limited is a relatively new player in the Indian fast-moving consumer healthcare (FMCG) market, having been incorporated in 2023. The company focuses on providing over-the-counter (OTC) health solutions, specializing in three key areas: allergy relief, physical wellness, and pain management. Its operations are primarily within India, leveraging a multifaceted distribution network to reach consumers.
The company's product portfolio boasts a collection of established and recognizable brands catering to diverse health needs. These include Allegra for allergy relief, Combiflam for pain relief and fever reduction, Avil, another allergy medication, DePURA for digestive health, Festal for digestive enzyme support, and Novalgin NU, also for pain relief. This breadth of offerings allows them to target a wide range of consumer demographics and health concerns.
Sanofi Consumer Healthcare India's distribution strategy is comprehensive, utilizing a multi-channel approach to reach its target market. This network includes partnerships with distributors and wholesalers, direct sales to government institutions and hospitals, supply to pharmacies and pharmacy chains, and an expanding presence in the e-commerce sector. This diversified approach ensures widespread availability and accessibility of their products across various retail channels.
The company's organizational structure positions it as a subsidiary of Sanofi India Limited, benefiting from the resources and established presence of its parent company. This affiliation provides access to established research and development capabilities, marketing expertise, and a well-recognized brand name, offering a significant advantage in a competitive market. Based in Mumbai, the company leverages its strategic location to effectively manage its operations within India.
Questions investors ask about Sanofi Consumer Healthcare India Ltd (SANOFICONR).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Sanofi Consumer Healthcare India Ltd (SANOFICONR)?
The current share price of Sanofi Consumer Healthcare India Ltd (SANOFICONR) is ₹4,616.9. Today, the stock has gained by ₹15.30 (0.33%), trading in a range of ₹4,592 to ₹4,680. The stock opened at ₹4,600 with a trading volume of 3,332 shares.
02Is Sanofi Consumer Healthcare India Ltd stock a good investment for long-term?
Sanofi Consumer Healthcare India Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹10,697.72 crores, P/E ratio of 41.29, ROE of 0.00%, and ROCE of 111.00%. The dividend yield stands at 1.63%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Sanofi Consumer Healthcare India Ltd stock?
The 52-week high price of Sanofi Consumer Healthcare India Ltd (SANOFICONR) is ₹0, while the 52-week low is ₹0. Currently trading at ₹4,616.9, the stock is Infinity% away from its 52-week low and -Infinity% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Sanofi Consumer Healthcare India Ltd stock at the current price?
Whether to buy Sanofi Consumer Healthcare India Ltd stock at ₹4,616.9 depends on multiple factors. The stock is currently trading with a P/E ratio of 41.29 and P/B ratio of 27.69. Today's performance shows a gain of 0.33%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Sanofi Consumer Healthcare India Ltd and when is the next dividend?
Sanofi Consumer Healthcare India Ltd offers a dividend yield of 1.63%, which means for every ₹100 invested at the current price of ₹4,616.9, you can expect to receive approximately ₹1.63 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Sanofi Consumer Healthcare India Ltd?
Sanofi Consumer Healthcare India Ltd's key financial metrics include: P/E Ratio: 41.29, P/B Ratio: 27.69, ROE: 0.00%, ROCE: 111.00%, Dividend Yield: 1.63%, EPS: ₹111.82, Book Value: ₹166.71, and Debt-to-Equity: 6.46. The company's market cap stands at ₹10,697.72 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Sanofi Consumer Healthcare India Ltd stock performing today in the market?
Sanofi Consumer Healthcare India Ltd stock opened at ₹4,600 and is currently trading at ₹4,616.9, showing a gain of ₹15.30 (0.33%). The intraday high is ₹4,680 and low is ₹4,592. The trading volume stands at 3,332 shares, indicating moderate market participation today.
08What is the P/E ratio of Sanofi Consumer Healthcare India Ltd and what does it indicate?
Sanofi Consumer Healthcare India Ltd has a Price-to-Earnings (P/E) ratio of 41.29, which means investors are willing to pay ₹41.29 for every ₹1 of earnings. With an EPS of ₹111.82, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Sanofi Consumer Healthcare India Ltd (SANOFICONR) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Share PricePeer
- Aarti Drugs (AARTIDRUGS) Share PricePeer
- Aarti Pharmalabs (AARTIPHARM) Share PricePeer
- Ajanta Pharma (AJANTPHARM) Share PricePeer
- Akums Drugs & Pharmaceuticals (AKUMS) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy